AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32485664 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min/day pedaling group
Number of subjects: 20
Study 32329887 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy plus aromatherapy
Number of subjects: 38
Study 32329887 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 38
Study 616866158 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video gaming using a motion-controlled video console (Nintendo Wii) for a minimum of 30 minutes a day, 5 days a week, plus weekly Internet-based coaching sessions
Number of subjects: 13
Study 616866158 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 13
Study 616866158 — intervention group
Group type: EXPERIMENTAL
Intervention: Active video gaming
Number of subjects: 13
Study 34229729 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant erythropoietin (EPREX) 300 units/Kg or 4000 IU subcutaneous injection three times a day for 5 days, along with Enoxaparin 1 mg/kg SQ daily.
Number of subjects: 20
Study 34229729 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) and placebo (distilled water) subcutaneous injection three times a day for 5 days.
Number of subjects: 20
Study 32892989 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 748463
Study 32892989 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 748463
Study 32892989 — intervention group
Group type: COMPARATOR
Intervention: Delayed Revascularization
Number of subjects: 748463
Study 615056321 — intervention group
Group type: EXPERIMENTAL
Intervention: PP3M
Number of subjects: 0
Study 615056321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 615056321 — intervention group
Group type: COMPARATOR
Intervention: PP1M
Number of subjects: 0
Study 36041767 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep needle insertion with combined manual and alternating-mode electrical stimulation on acupoints (AC group)
Number of subjects: 180
Study 36041767 — intervention group
Group type: COMPARATOR
Intervention: Superficial needle insertion without manual stimulation and electrical stimulation on non-acupoints (SAC group)
Number of subjects: 180
Study 36041767 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture intervention (NAC group)
Number of subjects: 180
Study 36041767 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (AC, SAC, NAC)
Number of subjects: 180
Study 34393130 — intervention group
Group type: EXPERIMENTAL
Intervention: Expasyl
Number of subjects: 60
Study 34393130 — intervention group
Group type: EXPERIMENTAL
Intervention: Magic Foam Cord
Number of subjects: 60
Study 34393130 — intervention group
Group type: EXPERIMENTAL
Intervention: Traxodent
Number of subjects: 60
Study 34393130 — intervention group
Group type: COMPARATOR
Intervention: Intergroup comparison between Magic Foam Cord and Traxodent
Number of subjects: 60
Study 33264161 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold riboflavin (4°C)
Number of subjects: 98
Study 33264161 — intervention group
Group type: COMPARATOR
Intervention: Control group (riboflavin at room temperature)
Number of subjects: 98
Study 33064039 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory distraction group (ADG)
Number of subjects: 54
Study 33064039 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual distraction group (VDG)
Number of subjects: 54
Study 33064039 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 54
Study 33429090 — intervention group
Group type: EXPERIMENTAL
Intervention: PTNS plus bladder training (BT)
Number of subjects: 60
Study 33429090 — intervention group
Group type: EXPERIMENTAL
Intervention: TTNS plus bladder training (BT)
Number of subjects: 60
Study 33429090 — intervention group
Group type: COMPARATOR
Intervention: Bladder training (BT)
Number of subjects: 60
Study 34190167 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron-midazolam combination therapy (group PM)
Number of subjects: 104
Study 34190167 — intervention group
Group type: COMPARATOR
Intervention: Palonosetron monotherapy (group P)
Number of subjects: 104
Study 32105972 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse practitioners
Number of subjects: 1601
Study 33068301 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin 5mg/day (n = 40)
Number of subjects: 120
Study 33068301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100mg/day (n = 40)
Number of subjects: 120
Study 33068301 — intervention group
Group type: COMPARATOR
Intervention: Traditional antidiabetic therapy (Control, n = 40)
Number of subjects: 120
Study 33222852 — intervention group
Group type: EXPERIMENTAL
Intervention: High milk allowance and finely ground (FG) starter feed
Number of subjects: 48
Study 33222852 — intervention group
Group type: EXPERIMENTAL
Intervention: High milk allowance and textured (TS) starter feed
Number of subjects: 48
Study 33222852 — intervention group
Group type: COMPARATOR
Intervention: Low milk allowance and finely ground (FG) starter feed
Number of subjects: 48
Study 33222852 — intervention group
Group type: COMPARATOR
Intervention: Low milk allowance and textured (TS) starter feed
Number of subjects: 48
Study 33222852 — intervention group
Group type: EXPERIMENTAL
Intervention: High milk allowance (regardless of starter type)
Number of subjects: 48
Study 33222852 — intervention group
Group type: EXPERIMENTAL
Intervention: Finely ground (FG) starter feeds (regardless of milk allowance)
Number of subjects: 48
Study 35771833 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian nonparametric discontinuity design (BNDD)
Number of subjects: 0
Study 35771833 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundalini Yoga meditation
Number of subjects: 0
Study 35771833 — intervention group
Group type: EXPERIMENTAL
Intervention: Running for political positions
Number of subjects: 0
Study 35771833 — intervention group
Group type: EXPERIMENTAL
Intervention: Alleged historical phantom border in the Netherlands
Number of subjects: 0
Study 34673765 — intervention group
Group type: EXPERIMENTAL
Intervention: Village-based ART refill by lay village health workers (VHWs) after same-day ART initiation
Number of subjects: 257
Study 34673765 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based ART refill after same-day ART initiation
Number of subjects: 257
Study 34673765 — intervention group
Group type: EXPERIMENTAL
Intervention: Village-based ART refill by VHWs
Number of subjects: 257
Study 34673765 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based ART refill
Number of subjects: 257
Study 35507135 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC-100 (six cycles)
Number of subjects: 0
Study 35507135 — intervention group
Group type: COMPARATOR
Intervention: AC (four cycles)
Number of subjects: 0
Study 35857827 — intervention group
Group type: EXPERIMENTAL
Intervention: OP-101 at 4 mg/kg
Number of subjects: 24
Study 35857827 — intervention group
Group type: EXPERIMENTAL
Intervention: OP-101 at 4 and 8 mg/kg
Number of subjects: 24
Study 35857827 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled OP-101 treatment arms
Number of subjects: 24
Study 35857827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 35857827 — intervention group
Group type: EXPERIMENTAL
Intervention: OP-101
Number of subjects: 24
Study 34288239 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line pembrolizumab (26 patients)
Number of subjects: 66
Study 34288239 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line atezolizumab, nivolumab, or pembrolizumab (40 patients)
Number of subjects: 66
Study 34288239 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 66
Study 33813267 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeon-delivered exercise prescription and activity tracker
Number of subjects: 18
Study 34370964 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa tea
Number of subjects: 21
Study 34370964 — intervention group
Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 21
Study 33460537 — intervention group
Group type: EXPERIMENTAL
Intervention: MiSight contact lenses (CLs) continued for 1 year (MiSight-C group)
Number of subjects: 55
Study 33460537 — intervention group
Group type: EXPERIMENTAL
Intervention: MiSight contact lenses (CLs) discontinued for 1 year (MiSight-D group)
Number of subjects: 55
Study 33460537 — intervention group
Group type: COMPARATOR
Intervention: Single vision spectacles continued for 1 year (SV-C group)
Number of subjects: 55
Study 32166492 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-derived fractional flow reserve (CT-FFR)
Number of subjects: 372
Study 34906747 — intervention group
Group type: EXPERIMENTAL
Intervention: Distinct treatments in multi-arm trials sharing a control group
Number of subjects: 0
Study 34906747 — intervention group
Group type: COMPARATOR
Intervention: Statistical adjustment guidance
Number of subjects: 0
Study 33421558 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg intravenously every 3 weeks for 16 cycles)
Number of subjects: 8
Study 33421558 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (840 mg intravenously every 3 weeks for 16 cycles)
Number of subjects: 8
Study 32313032 — intervention group
Group type: EXPERIMENTAL
Intervention: MR stimulation (0.4 mg fludrocortisone)
Number of subjects: 116
Study 32313032 — intervention group
Group type: EXPERIMENTAL
Intervention: NMDA stimulation (250 mg D-cycloserine (DCS))
Number of subjects: 116
Study 32313032 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined MR/NMDA stimulation (fludrocortisone + DCS)
Number of subjects: 116
Study 32313032 — intervention group
Group type: COMPARATOR
Intervention: Control condition (placebo)
Number of subjects: 116
Study 36040464 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.45% saline in 5% dextrose
Number of subjects: 200
Study 36040464 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline in 5% dextrose
Number of subjects: 200
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiologist visual score
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: BTS algorithm
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCP algorithm
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: Brock calculator
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG uptake (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: Herder probability (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiologist visual score (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: BTS algorithm (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: Brock probability (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study 32540198 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCP algorithm (in patients with FDG PET-CT scan, n = 78)
Number of subjects: 150
Study 34110620 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI-62
Number of subjects: 0
Study 32455501 — intervention group
Group type: EXPERIMENTAL
Intervention: Inset design
Number of subjects: 120
Study 32455501 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay round design
Number of subjects: 120
Study 32455501 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay oval design
Number of subjects: 120
Study 32455501 — intervention group
Group type: COMPARATOR
Intervention: All designs
Number of subjects: 120
Study 35712942 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (at Baihui, Yintang, Anmian, Hegu, Shenmen, Taichong, Taixi), once every other day, 3 times a week for 4 weeks
Number of subjects: 60
Study 35712942 — intervention group
Group type: COMPARATOR
Intervention: Oryzanol tablets, 20 mg orally, 3 times a day for 4 weeks
Number of subjects: 60
Study 33581146 — intervention group
Group type: EXPERIMENTAL
Intervention: Take-home kits for self-collection of swabs
Number of subjects: 2862
Study 33581146 — intervention group
Group type: COMPARATOR
Intervention: Trained research assistants obtaining swabs in the workplace
Number of subjects: 2862
Study 34763746 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional intervention (7-month duration) including group educational sessions, motivational cards, and informational materials.
Number of subjects: 3414
Study 34763746 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 3414
Study 33221116 — intervention group
Group type: EXPERIMENTAL
Intervention: SMOFlipid (SO/MCT/OO/fish oil)
Number of subjects: 67
Study 33221116 — intervention group
Group type: COMPARATOR
Intervention: MCT/LCT
Number of subjects: 67
Study 33221116 — intervention group
Group type: COMPARATOR
Intervention: OO/SO
Number of subjects: 67
Study 34038410 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training performed four times per week
Number of subjects: 98
Study 34038410 — intervention group
Group type: COMPARATOR
Intervention: Combined training performed two times per week
Number of subjects: 98
Study 34038410 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (both groups)
Number of subjects: 98
Study 32070184 — intervention group
Group type: EXPERIMENTAL
Intervention: Training design for the development of empathic interaction skills
Number of subjects: 62
Study 32070184 — intervention group
Group type: EXPERIMENTAL
Intervention: Training design for the development of conflict management skills
Number of subjects: 62
Study 616811449 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-containing meal
Number of subjects: 28
Study 35038950 — intervention group
Group type: EXPERIMENTAL
Intervention: Free spectacles group
Number of subjects: 1904
Study 35038950 — intervention group
Group type: COMPARATOR
Intervention: Voucher spectacles group
Number of subjects: 1904
Study 33597230 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal management with a thermal servo‐controlled system
Number of subjects: 450
Study 33597230 — intervention group
Group type: COMPARATOR
Intervention: Thermal management without a thermal servo‐controlled system
Number of subjects: 450
Study 34677647 — intervention group
Group type: EXPERIMENTAL
Intervention: OCV-501
Number of subjects: 134
Study 34677647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 34677647 — intervention group
Group type: EXPERIMENTAL
Intervention: OCV-501 (immune responders)
Number of subjects: 134
Study 34404426 — intervention group
Group type: EXPERIMENTAL
Intervention: Care manager organization
Number of subjects: 376
Study 34404426 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 376
Study 32546217 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey-protein-infused carbohydrate-loading drinks pre-operatively and early oral feeding post-operatively.
Number of subjects: 0
Study 32546217 — intervention group
Group type: COMPARATOR
Intervention: Fasted overnight pre-operation and only allowed plain water, return to a normal diet when bowel sounds return post-operatively.
Number of subjects: 0
Study 34696669 — intervention group
Group type: EXPERIMENTAL
Intervention: Autophagy-related signature based on six ARGs
Number of subjects: 0
Study 34696669 — intervention group
Group type: EXPERIMENTAL
Intervention: Signature-based risk score
Number of subjects: 0
Study 32669656 — intervention group
Group type: EXPERIMENTAL
Intervention: IBI301
Number of subjects: 181
Study 32669656 — intervention group
Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 181
Study 36135387 — intervention group
Group type: EXPERIMENTAL
Intervention: LSC plus LPP
Number of subjects: 130
Study 36135387 — intervention group
Group type: COMPARATOR
Intervention: LSC alone
Number of subjects: 130
Study 32654097 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglycosides (gentamicin, amikacin, tobramycin)
Number of subjects: 147
Study 32654097 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific pathogenic clone carrying ant(2" )-Ia
Number of subjects: 147
Study 32654097 — intervention group
Group type: EXPERIMENTAL
Intervention: MexXY-OprM efflux pump
Number of subjects: 147
Study 32654097 — intervention group
Group type: EXPERIMENTAL
Intervention: ant(2" )-Ia-encoded adenylyltransferase
Number of subjects: 147
Study 32246254 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training ball (OTB)
Number of subjects: 60
Study 32246254 — intervention group
Group type: COMPARATOR
Intervention: Classical olfactory training (COT)
Number of subjects: 60
Study 35055833 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile wellness program (12 weeks)
Number of subjects: 60
Study 35055833 — intervention group
Group type: COMPARATOR
Intervention: Control group (Fitbit only)
Number of subjects: 60
Study 34144923 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin liposome inhalation suspension (ALIS) 590 mg once daily for 12 treatment cycles (96 weeks)
Number of subjects: 206
Study 32822656 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiology-guided complete revascularization
Number of subjects: 1400
Study 32822656 — intervention group
Group type: COMPARATOR
Intervention: Culprit-only treatment
Number of subjects: 1400
Study 35025755 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Messaging for Men (M-cubed) app
Number of subjects: 1226
Study 35025755 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 1226
Study 32749547 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate laryngoscopy with intubation and suctioning
Number of subjects: 40
Study 32749547 — intervention group
Group type: COMPARATOR
Intervention: Immediate positive pressure ventilation (PPV) without intubation
Number of subjects: 40
Study 35700161 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage technique
Number of subjects: 19
Study 35700161 — intervention group
Group type: COMPARATOR
Intervention: Two-stage technique
Number of subjects: 19
Study 32506539 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact cord resuscitation
Number of subjects: 231
Study 32506539 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (CC)
Number of subjects: 231
Study 34494370 — intervention group
Group type: EXPERIMENTAL
Intervention: SisterTalk intervention (cable-TV-delivered weight-control program)
Number of subjects: 331
Study 33032485 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (DES)
Number of subjects: 173
Study 33032485 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 173
Study 33568152 — intervention group
Group type: COMPARATOR
Intervention: Vastus medialis obliquus and vastus lateralis muscle areas measured in sections 0, 5, 10, 15, and 20 mm above the upper pole of the patella.
Number of subjects: 61
Study 33568152 — intervention group
Group type: COMPARATOR
Intervention: Vastus medialis obliquus/vastus lateralis muscle area ratio at the upper pole of the patella (0 mm above the upper pole).
Number of subjects: 61
Study 33568152 — intervention group
Group type: COMPARATOR
Intervention: Sections 5, 10, 15, and 20 mm above the upper pole of the patella.
Number of subjects: 61
Study 32573910 — intervention group
Group type: EXPERIMENTAL
Intervention: N(t)RTI-based regimen
Number of subjects: 123
Study 32573910 — intervention group
Group type: COMPARATOR
Intervention: Raltegravir arm
Number of subjects: 123
Study 32573910 — intervention group
Group type: EXPERIMENTAL
Intervention: N(t)RTI randomization
Number of subjects: 123
Study 32573910 — intervention group
Group type: EXPERIMENTAL
Intervention: P1NP increase
Number of subjects: 123
Study 35708422 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling program based on the transtheoretical model (TM)
Number of subjects: 67
Study 35708422 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study 34167672 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed prasugrel 60-mg loading dose
Number of subjects: 441
Study 34167672 — intervention group
Group type: COMPARATOR
Intervention: Integral prasugrel 60-mg loading dose
Number of subjects: 441
Study 34167672 — intervention group
Group type: EXPERIMENTAL
Intervention: Crushed prasugrel
Number of subjects: 441
Study 34167672 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet reactivity <150 P2Y12 reactivity units at the beginning of coronary angiography
Number of subjects: 441
Study 32701118 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal Testosterone Cream (0.5 g daily for 2 weeks, then 0.5 g 3 times a week for 10 weeks)
Number of subjects: 0
Study 32701118 — intervention group
Group type: COMPARATOR
Intervention: Estradiol Vaginal Ring
Number of subjects: 0
Study 36057952 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic safinamide tablet (test), 100 mg
Number of subjects: 56
Study 36057952 — intervention group
Group type: COMPARATOR
Intervention: Brand-name safinamide tablet (reference), 100 mg
Number of subjects: 56
Study 34459033 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (18 mg in 1 ml of corn oil, injected SC)
Number of subjects: 12
Study 34459033 — intervention group
Group type: COMPARATOR
Intervention: Control (1 ml corn oil only)
Number of subjects: 12
Study 32340524 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy (perception that people can protect themselves from having a stroke)
Number of subjects: 552
Study 616186217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 56
Study 616186217 — intervention group
Group type: COMPARATOR
Intervention: 10-0 Vicryl sutures
Number of subjects: 56
Study 36235788 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA/EPA group (n = 33) - received six 480 mg capsules containing 576 mg DHA and 284 mg EPA per day for 12 weeks
Number of subjects: 66
Study 36235788 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (n = 33) - received corn oil for 12 weeks
Number of subjects: 66
Study 36235788 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA/EPA group (n = 33)
Number of subjects: 66
Study 33888136 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Lutein and 2 mg Zeaxanthin in safflower oil (Carotenoid group)
Number of subjects: 0
Study 33888136 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil with no added carotenoids (Control group)
Number of subjects: 0
Study 33402937 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine 30° HOBE
Number of subjects: 114